The Effects of Exenatide, a GLP-1 Agonist, on Alcohol Self-Administration in Heavy Drinkers

Clinical trial NCT03645408 · TERMINATED

Trial details

NCT number: NCT03645408
Sponsor: Boston Medical Center
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Alcohol Use Disorder

Start date: 2019-05-02
Primary completion: 2021-07-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.